Project 4: Profiling microprotein interactions in bacterial pathogen infections (Jyoti Choudhary)
London
Standard protein catalogs list only a fraction of what cells actually make.
Many lncRNAs, once assumed to be non-coding, in fact carry small open reading frames (smORFs) that ribosomes translate into short proteins, or microproteins, which standard reference catalogs miss. Which lncRNAs are actually translated, and how features of each transcript control the efficiency and location of that translation, remains poorly understood, especially in dynamic processes such as human neuronal differentiation.
This project will uncover the rules that govern lncRNA translation, mapping ribosome scanning with TCP-Seq (translation complex profile sequencing) in human SH‑SY5Y neuronal cells and resolving transcript structures with long‑read direct‑RNA‑Seq to pinpoint the regulatory motifs that set translation efficiency. It sits at the regulatory heart of ORFeus Work Package 2, which moves from discovering the dark proteome to understanding its function. The work connects closely to partner projects on single‑molecule translation mapping, single‑cell validation of candidate regulatory factors, the evolutionary analysis of translation features, and AI‑driven prediction of translation.
Methods and platforms : translation complex profile sequencing (TCP-Seq) and ribosome profiling in human SH‑SY5Y neuronal cell culture, long‑read direct‑RNA‑Seq (nanopore) to resolve transcript structures and functional dissection with mini‑gene reporters and siRNA knockdowns, data analysis, working with consortium datasets via the ORFeome platform.
Secondment : you will spend around three months at Oxford Nanopore Technologies (Oxford, UK), co-developing novel direct‑RNA‑Seq‑based translation profiling technologies. You will also be guided by an independent academic advisor, with the possibility of a short, primarily virtual research exchange to strengthen the project.
Candidates of any nationality may apply. There is no limit on prior research experience, as long as you do not already hold a doctorate.
Project‑specific profile
A full-time employment contract for 36 months as a salaried researcher, with full social security coverage, under the rules of the Marie Skłodowska‑Curie Actions. This is a paid employment contract, not a stipend or scholarship.
The salary has a living allowance and a mobility allowance, plus a family allowance if you have family obligations when you are recruited. The indicative gross salary for this position is €5,602.04 (£4,481.63) per month, whichincludes bothliving allowance and mobility allowance. This is what you are paid before income tax and your own social‑security contributions are deducted.
Beyond salary, you will receive:
The MSCA employment contract covers 36 months of full-time, fully funded employment.
The University of Leeds is a research-intensive university in the United Kingdom, with strong programs in molecular and cellular biology, RNA biology, and the life sciences. At the University of Leeds, we are committed to providing a culture of inclusion, respect and equity of opportunity that attracts, supports, and retains the best students and staff from all backgrounds and from across the world.
You will join the group of Prof. Julie Aspden, which studies how long non‑coding RNAs (lncRNAs) are translated, using ribosome profiling to map translation and its regulation during human neuronal differentiation. You will work closely with the group of Prof. Mar Alba at the Hospital del Mar Research Institute, who brings complementary expertise in the evolution and computational analysis of novel genes and microproteins. You will enroll as a PhD candidate at the University of Leeds Faculty of Health and Life Sciences Graduate School.
#J-18808-Ljbffr
Full job description from WhatJobs. Apply for this role →
London
Standard protein catalogs list only a fraction of what cells actually make.
Southampton
Only a fraction of the genome codes for the proteins in standard reference catalogues.
Belfast City District
AMPLY Discovery is an AI-enabled drug discovery company developing novel therapeutic programmes from underexplored areas of biology, including the…
London
A 2027 Crick-University College London Joint PhD project with James Briscoe (Crick) and Roberto Mayor (UCL).
Explore: Specialist jobs in Leeds
Worked with Verifera as a candidate or employer? Your honest review helps the next person trust verified hiring.